Skip to main content

Chris Mitton and Jack Riccardi

MDNA Life Science has appointed Chris Mitton as its CEO and Jack Riccardi as its CFO, effective immediately. Mitton has replaced former interim CEO George Steinfels, who will continue to support MDNA Life Sciences as a Board Advisor.  He previously has held sales roles at Abbott and Bayer Helathcare. In addition, Mitton has held senior commercial operations leadership positions at Ipsogen, Qiagen, and Cancer Genetics. Riccardi has held CFO position in both privately held and publicly traded entities including Omni Bio Pharmaceutical, ADial Pharmaceuticals, and Modern Visuals, over the past 10 years. Prior to that, he has held strategic finance roles, including as director of strategic planning and director of finance for General Motors. 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.